Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Frailty 12Neoplasms 11Ovarian Neoplasms 5Lymphoma 5Lung Neoplasms 4Breast Neoplasms 4Prostatic Neoplasms 3Multiple Myeloma 3Carcinoma, Non-Small-Cell Lung 3Lymphoma, Large B-Cell, Diffuse 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Treatment Adherence and Compliance 1Stomach Neoplasms 1Solid Neoplasm 1Sarcopenia 1Sarcoma 1Recurrence 1Prostate Cancer Cured 1Postoperative Complications 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1

Interventions

neratinib 1Geriatric Assessment 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × HER2 Positive Breast Carcinoma × Geriatric Assessment × Clear all
NCT02673398 2023-06-18

Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer

City of Hope Medical Center

Phase 2 Completed
25 enrolled 18 charts
Breast

HER2 Positive Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡